Study Shows Stereotactic Biopsy System Delivers Greater Accuracy In Detecting Cancer And Planning For Targeted Prostate Cancer Therapies

News — By on April 18, 2009 at 3:59 am

ATLANTA, GA and MOBILE, AL — Urologists convening this week at the Southeast Conference of the American Urological Association (AUA) in Mobile will deliver results from a study of a prostate biopsy targeting method that guides accurate and reproducible prostate biopsies. Additionally, the preliminary data shows that the stereotactic biopsy system, called TargetScan, may be used to guide delivery of targeted, focal prostate cancer therapies. “We now have greater confidence in diagnosing prostate disease and have much more accurate information to advise patients of their treatment options,” explains James K. Bennett, M.D., a leading urologist in private practice in Atlanta and co-author of the study. “Our study shows tha…

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback